Aammaad Shams - 01 Mar 2024 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Accounting Officer
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
01 Mar 2024
Net transactions value
-$88,399
Form type
4
Filing time
05 Mar 2024, 19:18:13 UTC
Previous filing
03 Aug 2023
Next filing
05 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +7,491 +15% $0.000000 57,515 01 Mar 2024 Direct F1, F2, F3
transaction EVH Class A Common Stock Tax liability $88,399 -2,569 -4.5% $34.41 54,946 01 Mar 2024 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027.
F3 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F4 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.